1. Micheliolide suppresses LPS-induced neuroinflammatory responses
    Zhaomeng Sun et al, 2017, PLoS ONE CrossRef
  2. Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes
    Yaozhen Chen et al, 2018, EBioMedicine CrossRef
  3. Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001
    Xiao-Nan Xi et al, 2018, Journal of Chromatography B CrossRef
  4. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
    Ning Xu et al, 2019, J Exp Clin Cancer Res CrossRef
  5. Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway
    Fenfen Peng et al, 2019, Lab Invest CrossRef
  6. Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge
    Xiangyang Qin et al, 2016, Sci Rep CrossRef
  7. Micheliolide provides protection of mice against Staphylococcus aureus and MRSA infection by down-regulating inflammatory response
    Xinru Jiang et al, 2017, Sci Rep CrossRef
  8. A directly GP130‐targeting small molecule ameliorates collagen‐induced arthritis (CIA) by inhibiting IL‐6/GP130 signalling and Th17 differentiation
    Yeon‐Hwa Park et al, 2020, Clin Exp Pharmacol Physiol CrossRef
  9. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Shunnan Yao et al, 2020, Cancer Lett CrossRef
  10. 3,5-Di-C-β-D-glucopyranosyl phloroacetophenone, a major component of Melicope ptelefolia, suppresses fibroblast activation and alleviates arthritis in a mouse model: Potential therapeutics for rheumatoid arthritis
    Hyun Jong Kim et al, 2018, Int J Mol Med CrossRef
  11. Long-term every-other-day administration of DMAMCL has little effect on aging and age-associated physiological decline in mice
    Zhaomeng Sun et al, 2019, Aging CrossRef
  12. NLRP3 inflammasome of renal tubular epithelial cells induces kidney injury in acute hemolytic transfusion reactions
    Zhixin Liu et al, 2021, Clinical and Translational Medicine CrossRef
  13. Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
    Yubo Dong et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  14. Micheliolide attenuates neuroinflammation to improve cognitive impairment of Alzheimer's disease by inhibiting NF-κB and PI3K/Akt signaling pathways
    Guizhen Yang et al, 2023, Heliyon CrossRef
  15. Micheliolide prevents estrogen deficiency-induced bone loss via inhibiting osteoclast bone resorption
    Ziyang Gan et al, 2023, Aging CrossRef
  16. Pharmacological potential of micheliolide: A focus on anti-inflammatory and anticancer activities
    Jalal Uddin et al, 2024, Heliyon CrossRef
  17. Sesquiterpene Lactones: Promising Natural Compounds to Fight Inflammation.
    Melanie S Matos et al, 2021, Pharmaceutics CrossRef
  18. The potential efficacy of sesquiterpenes and their derivatives in treating rheumatoid arthritis: A systematic review
    Jing Han et al, 2024, International Immunopharmacology CrossRef
  19. Micheliolide ameliorates severe acute pancreatitis in mice through potentiating Nrf2-mediated anti-inflammation and anti-oxidation effects
    Chen-Yu Wu et al, 2024, International Immunopharmacology CrossRef
  20. The Interaction of Methotrexate with the Human C5a and its Potential Therapeutic Implications
    Manaswini Ghosh et al, 2024, Computational Biology and Chemistry CrossRef